Catherine A Foss Selected Research

fialuridine

1/2020	Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [124I]FIAU PET/CT.
10/2008	Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.
10/2007	Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT.
3/2007	Virus-associated tumor imaging by induction of viral gene expression.
1/2005	Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine A Foss Research Topics

Disease

20	Neoplasms (Cancer) 01/2019 - 06/2005
15	Prostatic Neoplasms (Prostate Cancer) 09/2020 - 06/2005
4	Inflammation (Inflammations) 01/2022 - 12/2013
4	Infections 01/2022 - 01/2005
4	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2005
3	Tuberculosis (Tuberculoses) 01/2019 - 12/2013
3	Neuroinflammatory Diseases 01/2019 - 01/2018
2	Arthritis (Polyarthritis) 12/2017 - 01/2014
2	Schizophrenia (Dementia Praecox) 12/2016 - 02/2008
2	Mental Disorders (Mental Disorder) 04/2013 - 02/2008
2	Neoplasm Metastasis (Metastasis) 01/2013 - 07/2005
2	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2008 - 03/2007
1	COVID-19 01/2022
1	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Synucleinopathies 01/2019
1	Foreign Bodies (Foreign Body) 01/2019
1	Heart Failure 11/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Cerebral Hemorrhage 01/2018
1	Experimental Arthritis 12/2017
1	Chronic Pancreatitis 10/2017
1	Nervous System Diseases (Neurological Disorders) 12/2016
1	Alzheimer Disease (Alzheimer's Disease) 12/2016
1	Epilepsy (Aura) 12/2016
1	Neoplasm Micrometastasis 09/2015
1	Human Influenza (Influenza) 09/2015
1	Atherosclerosis 05/2015
1	Granuloma 01/2015
1	Encephalitis (Encephalitis, Rasmussen) 01/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2012
1	Marfan Syndrome (Marfan's Syndrome) 09/2012
1	Thyroid Neoplasms (Thyroid Cancer) 07/2011

Drug/Important Bio-Agent (IBA)

16	AntigensIBA 09/2020 - 06/2005
7	RadiopharmaceuticalsIBA 09/2015 - 06/2005
6	Biomarkers (Surrogate Marker)IBA 09/2020 - 07/2009
5	LigandsIBA 01/2022 - 06/2005
5	fialuridineIBA 01/2020 - 01/2005
4	Thymidine KinaseIBA 01/2020 - 01/2005
3	N,N- diethyl- 2- (2- (4- methoxyphenyl)- 5,7- dimethyl- pyrazolo(1,5- a)pyrimidin- 3- yl)- acetamideIBA 01/2019 - 12/2013
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2014
3	CollagenIBA 12/2017 - 09/2012
3	Pharmaceutical PreparationsIBA 01/2017 - 09/2009
3	Urea (Carbamide)FDA LinkGeneric 01/2016 - 09/2009
2	AndrogensIBA 09/2020 - 01/2013
2	Biological ProductsIBA 01/2018 - 01/2018
2	AcidsIBA 01/2016 - 12/2011
2	Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA 09/2009 - 02/2008
2	iodouracilIBA 10/2008 - 01/2005
2	Bortezomib (Velcade)FDA Link 10/2008 - 03/2007
2	Tyrosine (L-Tyrosine)FDA Link 02/2008 - 10/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 12/2019
1	SynucleinsIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Complement C3 (C3 Complement)IBA 01/2019
1	AerosolsIBA 01/2019
1	Dendrimers (Dendrons)IBA 01/2019
1	PAMAM StarburstIBA 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	DesminIBA 11/2018
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2018
1	HydrolasesIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 12/2017
1	CeruletideIBA 10/2017
1	Immunoglobulin Fab FragmentsIBA 05/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2016
1	CarbamatesIBA 01/2016
1	Histones (Histone)IBA 09/2015
1	CholesterolIBA 05/2015
1	Apolipoproteins E (ApoE)IBA 05/2015
1	Phenobarbital (Luminal)FDA Link 05/2015
1	ferric ferrocyanide (Prussian blue)FDA Link 03/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2014
1	Chelating AgentsIBA 08/2013
1	Dopamine (Intropin)FDA LinkGeneric 04/2013
1	Pertussis ToxinIBA 10/2012
1	Peptides (Polypeptides)IBA 10/2012
1	Cytidine Monophosphate (CMP)IBA 09/2012
1	Matrix Metalloproteinases (MMPs)IBA 09/2012
1	2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA 12/2011
1	pyridineIBA 12/2011
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2011
1	Drug CarriersIBA 01/2011
1	2- (3- (1- carboxy- 5- (4- iodobenzylamino)pentyl)ureido)pentanedioic acidIBA 09/2009
1	Lysine (L-Lysine)FDA Link 09/2009
1	2-(phosphonomethyl)pentanedioic acidIBA 09/2009
1	Glutamic Acid (Glutamate)FDA Link 09/2009
1	glutamate carboxypeptidaseIBA 09/2009
1	2- (3- (1- carboxy- 5- (3- (4- iodobphenyl)ureido)pentyl)ureido)pentanedioic acidIBA 09/2009

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2008
1	Investigational Therapies (Experimental Therapy) 09/2020
1	Truncal Vagotomy 01/2019
1	Aftercare (After-Treatment) 09/2015